Asia Pacific Infection control Market

Asia Pacific Infection Control Market Size

According to a latest market research report, the Asia-Pacific Infection control Market was estimated at USD 4,393 million in 2018 and it is expected to reach USD 7,356 million in 2025 at a compound annual rate of 7% over the 2018-2025 forecast period.

Microorganisms such as fungi, bacteria and viruses are the main infectious agents. Various types of infections include eye infections, hospital infections, skin infections, common infections of childhood, ear infections, sexually transmitted diseases, stomach and intestinal infections, lung and respiratory infections. Proper hand washing is the most effective way to prevent infections in hospitals. Other steps include the use of gloves and masks, keep up to date on immunizations, disinfectants and tissues in hands, and cover them during coughing or sneezing.

Growth Drivers, Challenges and Opportunities - Asia Pacific Infection Control Market

The market for infection control in the Asia Pacific is growing significantly due to the increasing number of surgeries and the number of hospitals. It is expected that supplies for the control of disinfectant infections will achieve significant participation in the market. The end user of the hospital should contribute with a strong participation in the regional market of supplies for infection control, such as the high demand for the control of infections in hospitals. However, the increasing incidence of nosocomial infections and increased awareness of various types of infections are the major factors driving the Asia Pacific market for infection control.

Government support for infection control is positively influencing the market. The different strategies adopted by many companies in the health sector such as mergers and acquisitions, new product launches, collaboration, the launch of new technologies are the main trends observed in the global market for infection control. Factors such as increased emphasis on sterilization and disinfection of food, which includes the technological advances in sterilization equipment and increased outsourcing of sterilization services to various pharmaceutical companies, hospitals and medical equipment manufacturers will spur this regional market.

However, strict guidelines for the approval of equipment used for sterilization makes the infection control market somewhat more difficult. The need of infection control in cancer treatment is expected to have significant growth potential in the coming years. Factors contributing to this assessment include increasing geriatric population base, increasing number of cancer patients, and advances in cancer treatment technologies. In addition, the growing public awareness of poor health and sanitation conditions in underdeveloped countries is expected to boost the market in Asia Pacific.

Geographical Analysis of Asia Pacific Infection Control Market

The Asia-Pacific market is expected to post the fastest compound annual growth rate over the forecast period due to the growing presence of outsourcing organizations, increased health care costs and unprecedented standards and health infrastructure in this region. The presence of several volunteer and government organizations dedicated to improving infection control standards is also one of the important factors contributing to the growth of the Asia-Pacific region. The growing trend of outsourcing established market players in developed economies to companies in the Asia-Pacific region is also a key growth driver for the market. The Asia-Pacific Infection Control Society (APSIC) is a voluntary organization that works to build partnerships to facilitate quality improvement and conduct infection control research to promote cost-effective practices in the field of infection control in the whole Asia Pacific region. India, China, Japan, Australia, etc., are the noteworthy regions for this regional market.

Few of the Key Players dominating the Asia Pacific Infection Control Market Profiled in the Report are:

• 3M
• TSO3 Inc.
• Nordion Inc.
• Synergy Health Plc.
• Cisa SpA
• Matachana Group
• STERIS Corporation
• Honeywell International Inc
• Johnson & Johnson Limited
• Getinge Group
• Ahlstrom
• Sterigenics International Inc.
• Kimberly-Clark
• Sakura Global Holding Company Ltd.
• Belimed AG.

This research report includes following segmentation for the Asia Pacific Infection Control Market size and forecast

Asia Pacific Infection Control Market - By Type of Equipment

• Sterilization Equipment
• Washing/Disinfection Equipment
• Others

Asia Pacific Infection Control Market - By Infection Control Services

• Infectious Waste Disposal Services
• Contract Sterilization Services

Asia Pacific Infection Control Market - By End User

• Hospitals and Clinics
• Medical Device Companies
• Pharmaceutical Companies
• Life Science Industries
• Food Industry
• Others

Asia Pacific Infection Control Market – By Region

• China
• India
• Japan
• South Korea